𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gene expression of DNA topoisomerases I, IIα and IIβ and response to cisplatin-based chemotherapy in advanced ovarian carcinoma

✍ Scribed by Mariagrazia Cornarotti; Giovanni Capranico; Silvia Bohm; Saro Oriana; Gian Battista Spatti; Luigi Mariani; Giuseppina Ballabio; Franco Zunino

Publisher
John Wiley and Sons
Year
1996
Tongue
French
Weight
765 KB
Volume
67
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to epirubicin in patients with
Response to epirubicin in patients with superficial bladder cancer and expression of the topoisomerase II α and β genes
✍ Sally L. Davies; Rick Popert; Malcolm Coptcoat; Ian D. Hickson; John R. W. Maste 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 460 KB 👁 2 views

OX3 SOU; 2Departrnent of Urology, Kings Biopsies of superficial bladder cancer were analysed to study the relationship between response to epirubicin and the expression of the human topoisomerase II a and p genes. Tissue samples were obtained prior to treatment and a marker tumour was left in the bl

Comparison of DNA topoisomerase IIα expr
Comparison of DNA topoisomerase IIα expression in small cell and nonsmall cell carcinoma of the lung: In search of a mechanism of chemotherapeutic response
✍ Donald G. Guinee Jr.; Joseph A. Holden; John R. Benfield; Madeline L. Woodward; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 803 KB

## BACKGROUND. Small cell carcinoma of the lung (SCLC) is distinguished from nonsmall cell carcinoma (NSCLC) by its exquisite initial sensitivity to chemotherapy. Antineoplastic drugs effective against SCLC include doxorubicin, etoposide, and others. Recently, the molecular target of these drugs h

A multicenter randomized phase II trial
A multicenter randomized phase II trial of granulocyte-colony stimulating factor-supported, platinum-based chemotherapy with flexible midcycle cisplatin administration in patients with advanced ovarian carcinoma
✍ Manuel Hidalgo; César Mendiola; José Manuel López-Vega; Daniel Castellano; Migue 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

The purpose of this study was to analyze whether the addition of granulocyte-colony stimulating factor (G-CSF) to platinum-based combination chemotherapy could increase platinum dose intensity and response rates and decrease hematologic toxicity in patients with advanced epithelial ovarian carcinoma